Skip to content

HCV at CROI: Growing Chasm Between Bench and Bedside

  • Chad Cipiti

Growing Chasm Between Bench and Bedside By Tracy Swan Hepatitis C virus (HCV) and HIV/HCV coinfection were prominently featured at this year's Retrovirus conference. Coverage ranged from scientific progress in the laboratory to treatment access in the clinic. During the…

Read more

Overlapping Epidemics: TB, HIV and Viral Hepatitis

  • Chad Cipiti

TB, HIV and Viral Hepatitis By Tracy Swan Disturbing reports of overlapping TB, HIV, and viral hepatitis epidemics emerged at the 2005 International AIDS Society Conference. In the newly independent states of Eastern Europe and Central Asia, HIV incidence continues…

Read more

Taylor-ed Treatment

  • Chad Cipiti

Brown University Clinician Leads the Way in Providing Competent Care to Coinfected Injectors By Tracy Swan Directly Observed Peg-IFN? A majority of the estimated 4 million hepatitis C virus (HCV) infections in the United States result from injection drug use…

Read more

TAG 2003: The Year at a Glance

  • Chad Cipiti

by Rob Camp January: starts as new TAG's Antiviral Project Director. Rob and Mark to Houston for ATAC structure meeting to develop stronger national coalition, then to D.C. for Federal AIDS Policy Partnership meeting. Talk of coming assault on Medicaid…

Read more

TAG at Ten: The Year 2002

  • Chad Cipiti

January: HIV vaccine papers in Nature by Merck's Emilio Emini, Harvard's Dan Barouch. February: First ATAC (AIDS Treatment Activist Conference) teach-in, Seattle (seventy people attend), followed by ATAC/BMS meeting and Retrovirus conference. NIH cancels large phase III canarypox HIV vaccine…

Read more
Back To Top